Navamedic ASA: Resignation of CFO

28 Nov 2025 17:05 CET

Oslo, 28 November 2025: Navamedic ASA ("Navamedic" or the "Company", OSE ticker:
"NAVA") announces that the Company and its Chief Financial Officer (CFO), Lars
Hjarrand, today has entered into an agreement whereby Hjarrand will step down as
CFO of the Company to pursue new opportunities outside the Company. Director of
Group Accounting, Pål Zimmermann Vonen will assume the role as acting CFO until
a new permanent CFO has been appointed.


"We wish to express our gratitude to Lars for his dedicated service and valuable
contributions to the Company's growth and development, and wish him all the best
for the future", said Kathrine Gamborg Andreassen, CEO of Navamedic.


For further information, please contact:


Kathrine Gamborg Andreassen, CEO, Mobile: +47 951 78 680 E-mail:
kathrine@navamedic.com.

About Navamedic
Navamedic ASA is a Nordic pharmaceutical company dedicated to enhancing people's
quality of life by being a reliable supplier of high-quality prescription,
consumer health, and hospital products to hospitals and pharmacies. Our growing
product portfolio has been carefully selected to meet current public health
concerns, such as obesity, Parkinson's disease, addiction, metabolism and
antibiotics, to empower people to live healthier and more fulfilling lives.
What sets us apart is our deep-rooted commitment to understanding the needs and
requirements of the countries where we are present. Our local insight and
competence enable us to understand the specific needs of each country where we
operate and ultimately to gain market access. This makes us a preferred partner
for international companies expanding their footprint across the Nordics and
Benelux regions, through either in-licensing or out-licensing. Navamedic has
been listed on the Oslo Stock Exchange since 2006 (ticker: NAVA) and is
headquartered in Oslo, Norway. For more information, please visit
www.Navamedic.com

This information is subject to the disclosure requirements pursuant to Section 5
-12 the Norwegian Securities Trading Act.

kga@navamedic.com

Navamedic ASA is a Nordic pharma company and a reliable supplier of high-quality
products, delivered to hospitals and through pharmacies, meeting the specific
medical needs of patients and consumers. Navamedic is present in all Nordic
countries, the Baltics and Benelux and has sales of specific products even in
other European countries like UK and Greece. Our headquarter is in Oslo, Norway
and we are listed on the Oslo Stock Exchange (ticker: NAVA). For more
information, please visit www.navamedic.com

More information:
Access the news on Oslo Bors NewsWeb site

660892_NAVA_Stock_exchange_announcement_28112025.pdf